Anacardic Acid (Hydroginkgolic acid), a natural product isolated from cashew nut shell liquid, is a potent inhibitor of p300 and p300/CBP-associated factor histone acetyltranferases, which also has antibacterial activity, antimicrobial activity, prostaglandin synthase inhibition, and tyrosinase and lipoxygenase inhibition. Anacardic acid regulates the activity and expression of several other crucial enzymes including NFκB kinase, lipoxygenase (LOX-1), xanthine oxidase, tyrosinase and ureases. Therefore, this compound exerts anti-oxidation, anti-inflammation and anti-tumor activities in vitro and in vivo.
Physicochemical Properties
| Molecular Formula | C22H36O3 | |
| Molecular Weight | 348.52 | |
| Exact Mass | 348.266 | |
| CAS # | 16611-84-0 | |
| Related CAS # |
|
|
| PubChem CID | 167551 | |
| Appearance | White to off-white solid powder | |
| Density | 1.0±0.1 g/cm3 | |
| Boiling Point | 474.8±33.0 °C at 760 mmHg | |
| Melting Point | 90-91℃ | |
| Flash Point | 255.1±21.9 °C | |
| Vapour Pressure | 0.0±1.2 mmHg at 25°C | |
| Index of Refraction | 1.515 | |
| LogP | 9.96 | |
| Hydrogen Bond Donor Count | 2 | |
| Hydrogen Bond Acceptor Count | 3 | |
| Rotatable Bond Count | 15 | |
| Heavy Atom Count | 25 | |
| Complexity | 329 | |
| Defined Atom Stereocenter Count | 0 | |
| InChi Key | ADFWQBGTDJIESE-UHFFFAOYSA-N | |
| InChi Code | InChI=1S/C22H36O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19-17-15-18-20(23)21(19)22(24)25/h15,17-18,23H,2-14,16H2,1H3,(H,24,25) | |
| Chemical Name | 2-Hydroxy-6-pentadecyl-benzoic acid | |
| Synonyms |
|
|
| HS Tariff Code | 2934.99.9001 | |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
|
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | Histone acetyltransferase anacardic acid (IC50 of ~8.5 μM and ~5 μM, respectively) inhibits the HAT activities of p300 and PCAF [1]. Hyphalite growth is inhibited by anacardic acid (300 μM). In M, anacardic acid (50 μM) causes apoptosis-like traits. oryzae; caspase has no bearing on its function. Mitochondrial potential is lost when exposed to anacardic acid (1–80 μM). Antioxidant action is demonstrated by anacardic acid (1-60 μM) in M. oryzae. | ||
| ln Vivo | Anacardic acid (5 mg/kg, ip) attenuates HAT binding to the MEF2A promoter and rescues phenylephrine-induced H3K9ac hyperacetylation in C57BL/6 mice. Anacardic Acid inhibits the transcription levels of MEF2A and cardiac development-related downstream genes, attenuates the protein overexpression of cardiac downstream genes caused by phenylephrine, reverses and attenuates cardiac hypertrophy in the hearts of mice exposed to phenylephrine, and attenuates left ventricular pressure and improve cardiac function in mice with cardiac hypertrophy [2]. | ||
| Animal Protocol |
|
||
| References |
[1]. Small molecule modulators of histone acetyltransferase p300. J Biol Chem. 2003 May 23;278(21):19134-40. Epub 2003 Mar 6. [2]. Phenylephrine-induced cardiac hypertrophy is attenuated by a histone acetylase inhibitor anacardic acid in mice. Mol Biosyst. 2017 Mar 28;13(4):714-724. [3]. Anacardic acid induces apoptosis-like cell death in the rice blast fungus Magnaporthe oryzae. Appl Microbiol Biotechnol. 2016 Jan;100(1):323-35. |
||
| Additional Infomation |
Anacardic acid is a hydroxybenzoic acid that is salicylic acid substituted by a pentadecyl group at position 6. It is a major component of cashew nut shell liquid and exhibits an extensive range of bioactivities. It has a role as an EC 2.3.1.48 (histone acetyltransferase) inhibitor, an apoptosis inducer, a neuroprotective agent, an EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor, an anticoronaviral agent, an antibacterial agent, an anti-inflammatory agent and a plant metabolite. It is a hydroxybenzoic acid and a hydroxy monocarboxylic acid. It is functionally related to a salicylic acid. Anacardic acid has been reported in Ozoroa insignis, Knema elegans, and other organisms with data available. |
Solubility Data
| Solubility (In Vitro) |
|
|||
| Solubility (In Vivo) |
Solubility in Formulation 1: 10 mg/mL (28.69 mM) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 100.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 2: 2.5 mg/mL (7.17 mM) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), suspension solution; with ultrasonication. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (7.17 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.8693 mL | 14.3464 mL | 28.6928 mL | |
| 5 mM | 0.5739 mL | 2.8693 mL | 5.7386 mL | |
| 10 mM | 0.2869 mL | 1.4346 mL | 2.8693 mL |